Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies.

Elsebaie, Maha A T; Baral, Binav; Elsebaie, Mai; Shrivastava, Trilok; Weir, Catherine; Kumi, Dennis; Birch, Noah W

Elsebaie, Maha A T; Baral, Binav; Elsebaie, Mai; Shrivastava, Trilok; Weir, Catherine; Kumi, Dennis; Birch, Noah W.

Afiliação

Elsebaie MAT; Department of Hematology and Medical Oncology, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States.
Baral B; Department of Hematology and Medical Oncology, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States.
Elsebaie M; Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Shrivastava T; Department of Hematology and Medical Oncology, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States.
Weir C; Department of Hematology and Medical Oncology, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States.
Kumi D; Department of Hematology and Medical Oncology, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States.
Birch NW; Department of Hematology and Medical Oncology, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States.

TH Open ; 6(4): e323-e334, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36299621

Palavras-chave

COVID-19; bleeding; therapeutic anticoagulation; thromboprophylaxis; thrombosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: TH Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google